Keros Therapeutics, Inc.（KROS）内部人交易：高管与董事近期交易
过去 18 个月，共有 28 位内部人为 Keros Therapeutics, Inc.（KROS）报告了 101 笔 Form 4 交易（最近一笔 2026-08-20）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-20 | Newton Charles W. | 董事 | 卖出 | 551 | $5,675 |
| 2026-08-20 | Lerner Lorena Raquel | Chief Scientific Officer | 卖出 | 3,568 | $36,715 |
| 2026-08-20 | Cho Esther | Chief Legal Officer | 卖出 | 4,485 | $46,151 |
| 2026-08-20 | Tanini Annita | Corp. Controller & VP, Finance | 卖出 | 1,224 | $12,595 |
| 2026-08-19 | BIENAIME JEAN JACQUES | 董事 | 买入 | 1,000 | $10,270 |
| 2026-07-17 | BIENAIME JEAN JACQUES | 董事 | 买入 | 1,000 | $10,610 |
| 2026-07-06 | Prener Anne | 董事 | 买入 | 13,786 | $0 |
| 2026-06-17 | BIENAIME JEAN JACQUES | 董事 | 买入 | 1,000 | $10,190 |
| 2026-06-15 | Newton Charles W. | 董事 | 卖出 | 550 | $5,522 |
| 2026-06-08 | Farzan Nima | 董事 | 卖出 | 2,625 | $28,166 |
| 2026-06-08 | Knowles Julius | 董事 | 卖出 | 2,625 | $28,166 |
| 2026-06-05 | BIENAIME JEAN JACQUES | 董事 | 买入 | 7,142 | $0 |
| 2026-06-05 | Seth Alpna | 董事 | 买入 | 7,142 | $0 |
| 2026-06-05 | Farzan Nima | 董事 | 买入 | 7,142 | $0 |
| 2026-06-05 | Knowles Julius | 董事 | 买入 | 7,142 | $0 |
| 2026-06-05 | Seth Alpna | 董事 | 卖出 | 2,625 | $28,140 |
| 2026-06-05 | GRAY MARY ANN | 董事 | 买入 | 7,142 | $0 |
| 2026-05-19 | BIENAIME JEAN JACQUES | 董事 | 买入 | 1,000 | $10,580 |
| 2026-04-17 | BIENAIME JEAN JACQUES | 董事 | 买入 | 1,000 | $11,700 |
| 2026-04-06 | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | 买入 | 55,000 | $16,500 |
| 2026-03-11 | BIENAIME JEAN JACQUES | 董事 | 买入 | 2,000 | $22,420 |
| 2026-03-11 | Newton Charles W. | 董事 | 买入 | 13,215 | $0 |
| 2026-02-20 | Lerner Lorena Raquel | Chief Science Officer | 卖出 | 3,873 | $63,324 |
| 2026-02-20 | Cho Esther | SVP, General Counsel | 卖出 | 4,745 | $77,581 |
| 2026-02-20 | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | 卖出 | 7,015 | $113,433 |
来源：SEC Form 4 申报文件 · 截至 2026-08-20